Actively Recruiting
Elbow Artery Embolization for Tennis Elbow
Led by Siddharth Padia, MD · Updated on 2026-03-23
25
Participants Needed
1
Research Sites
249 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this clinical research study is to examine whether embolization treatment of an elbow artery is a safe and effective way to treat elbow pain, specifically pain from tennis elbow. Embozene is a medical device made by Varian marketed in the United States for the treatment of hypervascular tumors and arteriovenous malformations. It consists of thousands of microscopic spheres that are injected into the artery to block the flow of blood to a specific region. One of the causes of pain in the setting of tennis elbow is increased blood flow going to the specific area of pain. In this study, we will investigate an experimental procedure to decrease the blood flow (embolize) to the specific region of the elbow that is causing the pain. This will be done by infusing Embozene particles into the specific blood vessel supplying the area of pain in the elbow. This is an investigational study to evaluate the safety and efficacy of elbow artery embolization (EAE) for the treatment of symptomatic lateral epicondylitis (tennis elbow).
CONDITIONS
Official Title
Elbow Artery Embolization for Tennis Elbow
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of lateral epicondylitis based on history and physical exam
- Ability to provide informed consent
- Life expectancy greater than 12 months
- Moderate to severe lateral elbow pain with visual analog scale score greater than 4 during physical activity
- Resistant or failed conservative treatments such as NSAIDs, physical therapy, or steroid joint injections for at least 6 months
You will not qualify if you...
- Mild elbow pain with visual analog scale score less than 4
- Chronic renal insufficiency with serum creatinine greater than 2 mg/dL
- Allergy to iodinated contrast agents not responsive to steroid management
- Active infection or malignancy
- Prior surgery on the affected elbow
- Uncorrectable bleeding disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, Los Angeles
Los Angeles, California, United States, 90095
Actively Recruiting
Research Team
A
Aniket Joglekar
CONTACT
S
Siddharth A Padia, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here